Search results
FDA vaccine advisers vote unanimously in favor of updated Covid-19 shot for fall
CNN.com· 3 days agoThe committee voted on the question, “For the 2024-2025 Formula of COVID-19 vaccines in the U.S.,...
What should you do if you’re still testing positive for COVID-19 after day 10?
The Today Show via AOL· 4 days agoAnd even young, healthy people can develop potentially serious complications, such as long COVID....
Pfizer's Paxlovid fails as 15-day treatment for long COVID, study finds
FOX Business· 2 hours agoA 15-day course of Pfizer's COVID-19 antiviral treatment Paxlovid did not relieve symptoms of long ...
FDA Panel Recommends New COVID Vaccines For JN.1 Lineage By Fall
Forbes· 4 days agoA Food and Drug Administration expert panel voted Wednesday to manufacture new COVID-19 vaccines to...
Column: After smearing Anthony Fauci, House Republicans proceed to defame a prominent vaccine...
Los Angeles Times· 2 days agoPeter J. Hotez is one of America’s most prominent vaccine experts. A professor at Baylor College of...
A Startling New Study Found That 75% of Past COVID Patients May Suffer From This Heart Condition
Parade via AOL· 3 days agoHow Can You Protect Yourself From COVID-19-Related Cardiovascular Issues? Get your COVID-19 ...
The new technology inside COVID-19 vaccines— mRNA
KRGV Rio Grande Valley· 6 days agoWhen you think of vaccines, you may think about traditional vaccines with weak or inactive parts of a virus to trigger an immune response. Today...
Quick Takes: US COVID-19 levels, H5N1, and Polio
Center for Infectious Disease Research and Policy· 1 day agoThe last data from the CDC show upticks in early COVID-19 indicators, but severity indicators remain unchanged from the previous week.
COVID vaccine makers ready updated shots for fall immunization drive (NYSE:PFE)
Seeking Alpha· 3 days agoPfizer (PFE), BioNTech (BNTX), Moderna (MRNA) and Novavax (NVAX) reaffirm commitment to provide...
3 Stocks With Mouthwatering Dividends You Can Buy Right Now
Motley Fool via Yahoo Finance· 14 hours agoThis is admittedly not an ideal formula for growth. However, I think the worst is over for Pfizer's ...